Skip to content

Inflammatory Biomarkers as Predictors of PONV Following Pediatric Orchiopexy

Association of Preoperative Inflammatory Biomarkers With Postoperative Nausea and Vomiting in Children Undergoing Orchiopexy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07148063
Enrollment
170
Registered
2025-08-29
Start date
2025-09-08
Completion date
2026-03-27
Last updated
2025-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Biomarkers, Pediatric Anesthesia, Postoperative Nausea and Vomiting (PONV)

Keywords

Pediatric anesthesia, Orchiopexy, Postoperative Nausea and Vomiting (PONV), Inflammatory biomarkers

Brief summary

Orchiopexy is a common surgical procedure for the treatment of cryptorchidism in the pediatric population, with a high incidence of postoperative nausea and vomiting (PONV). Recent evidence suggests that systemic inflammation may contribute to PONV pathogenesis, and preoperative inflammatory biomarkers such as NLR, PLR, SII, MLR, and SIRI could serve as predictive indicators. This prospective observational study aims to evaluate the relationship between these biomarkers and PONV incidence in children undergoing orchiopexy.

Interventions

Blood samples will be collected preoperatively to measure inflammatory biomarkers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index, monocyte-to-lymphocyte ratio (MLR), and systemic inflammation response index. These values will be analysed in relation to the incidence of postoperative nausea and vomiting within the first 6 hours after pediatric orchiopexy. No experimental drug or device will be administered as part of the study; all procedures will be conducted within the scope of standard perioperative care.

Sponsors

Diskapi Yildirim Beyazit Education and Research Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged between 1 and 8 years * Patients with ASA physical status I-II * Patients scheduled for elective orchiopexy * Obtained written informed consent from parents/guardians

Exclusion criteria

* Patients younger than 1 year or older than 8 years * Patients with ASA physical status III or higher * Presence of acute infection signs * History of previous nausea or vomiting

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Postoperative Nausea and Vomiting (PONV)Within 6 hours postoperativelyPONV will be assessed using a standardized nausea-vomiting scoring system by an anesthesiologist blinded to biomarker results.

Secondary

MeasureTime frameDescription
Need for Antiemetic TreatmentWithin 6 hours postoperativelyThe number of patients who receive at least one dose of rescue antiemetic medication will be recorded within the first 6 hours after surgery.

Countries

Turkey (Türkiye)

Contacts

Primary ContactElif Şule Özdemir Sezgi
elifsule-91@hotmail.com00905059209638
Backup ContactAslı Dönmez
aslidonmez@hotmail.com00905322256473

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026